Home » Topics » BioWorld Science

BioWorld Science
RSS

New Wnt signaling activators identified at Biosplice Therapeutics

Dec. 9, 2021

Edgewise Therapeutics patents myosin inhibitors

Dec. 9, 2021

New ENPP1 inhibitors discovered at Vir Biotechnology

Dec. 9, 2021

New CDK9/cyclin T1 inhibitors identified at Algen Biotechnologies

Dec. 9, 2021

Shanghai Meiyue Biotech Development describes new coagulation factor XIa inhibitors

Dec. 9, 2021

New model for studying early embryonic development

Dec. 9, 2021

Attenuated T. gondii injection synergizes with PD-L1 checkpoint blockade against mouse tumors

Dec. 9, 2021

Proteogenomics approach identifies neoantigens for T-cell immunotherapy in pediatric brain tumors

Dec. 9, 2021

GreenLight and IAVI partner on mRNA vaccine candidate for SARS-CoV-2 Omicron variant

Dec. 7, 2021

Bsense reports preclinical data on BSEN-627 in rat pain model

Dec. 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...